Breaking News Instant updates and real-time market news.

2021-02-17 07:43:48 CSOD Cornerstone OnDemand $46.30 / -1.08 (-2.28%) 07:43 02/17/21 02/17 07:43 02/17/21 07:43	Barclays boosts Cornerstone target, says start paying attention again Barclays analyst Raimo Lenschow raised the firm's price target on Cornerstone OnDemand to $60 from $51 and keeps an Overweight rating on the shares following last night's Q4 results. Investors should start to pay attention to Cornerstone again, Lenschow tells investors in a research note. Following the controversial Saba acquisition last year, we have now seen several quarters of better than expected results, says the analyst. Further, Lenschow believes the fiscal 2021 guidance looks conservative and has potential for further upside.
CSOD Cornerstone OnDemand $46.30 / -1.08 (-2.28%) 02/17/21 Mizuho Cornerstone OnDemand price target raised to $45 from $36 at Mizuho 02/17/21 JMP Securities Cornerstone OnDemand price target raised to $83 from $61 at JMP Securities 01/11/21 Barclays Cornerstone OnDemand price target raised to $51 from $48 at Barclays 11/09/20 BMO Capital Cornerstone OnDemand price target raised to $47 from $39 at BMO Capital

2021-02-17 07:43:48

CSOD

Cornerstone OnDemand

$46.30 / -1.08 (-2.28%)

07:43

02/17/21

02/17

07:43

02/17/21

07:43

Barclays boosts Cornerstone target, says start paying attention again

Barclays analyst Raimo Lenschow raised the firm's price target on Cornerstone OnDemand to $60 from $51 and keeps an Overweight rating on the shares following last night's Q4 results. Investors should start to pay attention to Cornerstone again, Lenschow tells investors in a research note. Following the controversial Saba acquisition last year, we have now seen several quarters of better than expected results, says the analyst. Further, Lenschow believes the fiscal 2021 guidance looks conservative and has potential for further upside.

CSOD Cornerstone OnDemand

$46.30 / -1.08 (-2.28%)

02/17/21 Mizuho: Cornerstone OnDemand price target raised to $45 from $36 at Mizuho

02/17/21 JMP Securities: Cornerstone OnDemand price target raised to $83 from $61 at JMP Securities

01/11/21 Barclays: Cornerstone OnDemand price target raised to $51 from $48 at Barclays

11/09/20 BMO Capital: Cornerstone OnDemand price target raised to $47 from $39 at BMO Capital

TODAY'S FREE FLY STORIES

Downgrade	Cadence Bancorp downgraded to Hold from Buy at Truist » 07:28 04/13/21 04/13 07:28 04/13/21 07:28 CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) , BXS BancorpSouth $30.45 / -1.79 (-5.55%) Truist analyst Jennifer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CADE BXS CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 04/12/21 Cadence Bancorp rises 7.1% 04/12/21 BancorpSouth, Cadence Bancorp announce all-stock merger agreement 01/25/21 Cadence Bancorp reports book value per share $15.83 as of December 31 01/25/21 Cadence Bancorp raises dividend to 15c BXS BancorpSouth $30.45 / -1.79 (-5.55%) 04/12/21 BancorpSouth, Cadence Bancorp announce all-stock merger agreement 04/07/21 BancorpSouth gets FDIC approval of mergers with National United, FNS Bancshares 01/13/21 BancorpSouth Bank to acquire FNS Bancshares for $90.04 per share 12/09/20 BancorpSouth announces new 6M share repurchase authorization CADE BXS CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 06:37 Today Raymond James Cadence Bancorp downgraded to Market Perform from Outperform at Raymond James 06:10 Today RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 04/12/21 RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 02/23/21 Stephens Stephens raises Regions price target to $23, sees possible deal for Cadence BXS BancorpSouth $30.45 / -1.79 (-5.55%) 06:10 Today RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 12/03/20 Stephens National United deal shouldn't preclude more M&A at BancorpSouth, says Stephens 11/16/20 DA Davidson BancorpSouth downgraded to Neutral from Buy at DA Davidson 11/16/20 DA Davidson BancorpSouth downgraded to Neutral from Buy at DA Davidson CADE BXS CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 01/25/21 Cadence Bancorp reports Q4 adjusted EPS $1.57, consensus $1.48 10/21/20 Cadence Bancorp reports Q3 EPS 40c, consensus 19c BXS BancorpSouth $30.45 / -1.79 (-5.55%) 01/25/21 BancorpSouth reports Q4 operating EPS ex MSR 69c, consensus 62c 10/21/20 BancorpSouth reports Q3 EPS 69c, consensus 53c CADE CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 01/07/21 Fly Intel: After-Hours Movers 04/22/21 Cadence Bancorp - CADE 04/22/21 BancorpSouth - BXS 05/06/21 Cadence Bancorporation
General news	European stock markets are mostly higher, » 07:25 04/13/21 04/13 07:25 04/13/21 07:25 $ECON Economic Data / + European stock markets… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
Conference/Events	Immunocore to host conference call » 07:25 04/13/21 04/13 07:25 04/13/21 07:25 IMCR Immunocore $32.22 / -3.28 (-9.24%) Management discusses… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events IMCR Immunocore $32.22 / -3.28 (-9.24%) 03/25/21 Immunocore expects cash to fund requirement through at least the end of 2022 02/19/21 Immunocore's tebentafusp granted Breakthrough Therapy Designation IMCR Immunocore $32.22 / -3.28 (-9.24%) 03/02/21 Jefferies Immunocore initiated with a Buy at Jefferies 03/02/21 JPMorgan Immunocore initiated with an Overweight at JPMorgan 03/02/21 Goldman Sachs Immunocore initiated with a Neutral at Goldman Sachs IMCR Immunocore $32.22 / -3.28 (-9.24%) 03/25/21 Immunocore reports 2020 EPS (GBP2.79) vs. (GBP4.66) last year 05 Feb IMCR Immunocore $32.22 / -3.28 (-9.24%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 07:30 Today Immunocore - IMCR
Conference/Events	Auris Medical to host business news update conference call » 07:25 04/13/21 04/13 07:25 04/13/21 07:25 EARS Auris Medical $4.26 / -0.015 (-0.35%) Management provides a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Periodicals On The Fly Events Options EARS Auris Medical $4.26 / -0.015 (-0.35%) 03/31/21 Auris Medical sees 2021 total cash needs CHF11.5M-CHF13M 01/29/21 Auris Medical initiates clinical investigation of AM-301 in allergic rhinitis 12/01/20 Auris Medical reports in vitro efficacy data from AM-301 10/13/20 Auris Medical initiates Part B of TRAVERS Phase 2 study of AM-125 EARS Auris Medical $4.26 / -0.015 (-0.35%) 03/31/21 Auris Medical reports 2020 EPS (CHF1.36) vs. (CHF2.28) last year EARS Auris Medical $4.26 / -0.015 (-0.35%) 03/19/21 Auris Medical to be issued U.S. patent for tinnitus, Patent Grants says EARS Auris Medical $4.26 / -0.015 (-0.35%) 03/09/21 Second Sight, Auris Medical soar as 'meme stock' mania continues 08:00 Today Auris Medical - EARS EARS Auris Medical $4.26 / -0.015 (-0.35%) 03/23/21 Largest borrow rate increases among liquid names 03/22/21 Largest borrow rate increases among liquid names 03/15/21 Largest borrow rate increases among liquid names 03/12/21 Largest borrow rate increases among liquid names
Syndicate	TripAdvisor announces pricing of Global Offering » 07:24 04/13/21 04/13 07:24 04/13/21 07:24 TRIP TripAdvisor $51.17 / -1.27 (-2.42%) announced the pricing of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 03/24/21 TripAdvisor, Reckitt announce partnership 03/22/21 TripAdvisor announces $300M convertible notes offering 02/18/21 TripAdvisor sees Q1 revenue, adjusted EBITDA roughly in line with 4Q20 02/18/21 TripAdvisor: January revenue performance dipped slightly relative to December TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 07:10 Today Jefferies TripAdvisor price target raised to $29 from $24 at Jefferies 04/05/21 Evercore ISI TripAdvisor assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research TripAdvisor initiated with a Peer Perform at Wolfe Research 03/12/21 Truist TripAdvisor price target raised to $62 from $48 at Truist TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 02/18/21 TripAdvisor reports Q4 adjusted EPS (41c), consensus (25c) 02/18/21 Notable companies reporting after market close 11/06/20 TripAdvisor expects Q4 revenue to be modestly lower than Q3, consensus $174.93M 11/05/20 TripAdvisor reports Q3 adjusted EPS (17c), consensus (26c) TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 01/08/21 Another Tesla upgrade among today's top calls on Wall Street 12/02/20 Fly Intel: Pre-market Movers TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 03/24/21 Unusually active option classes on open March 24th 03/05/21 Unusually active option classes on open March 5th 03/03/21 TripAdvisor call volume above normal and directionally bullish 02/26/21 TripAdvisor call volume above normal and directionally bullish

Upgrade	Ameren upgraded to Buy from Neutral at BofA » 07:24 04/13/21 04/13 07:24 04/13/21 07:24 AEE Ameren $80.70 / +0.15 (+0.19%) BofA analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AEE Ameren $80.70 / +0.15 (+0.19%) 03/12/21 Ameren CFO Moehn sells 10,000 common shares 02/12/21 Ameren trading resumes 02/12/21 Ameren boosts quarterly dividend to 55c per share from 51.5c 02/12/21 Ameren trading halted, news pending AEE Ameren $80.70 / +0.15 (+0.19%) 07:01 Today BofA Ameren upgraded to Buy from Neutral at BofA 04/08/21 Mizuho Ameren initiated with a Neutral at Mizuho 11/18/20 Barclays Ameren upgraded to Equal Weight from Underweight at Barclays 09/21/20 Barclays Ameren downgraded to Underweight from Equal Weight at Barclays AEE Ameren $80.70 / +0.15 (+0.19%) 02/18/21 Ameren sees FY21 adjusted EPS $3.65-$3.85, consensus $3.77 02/18/21 Ameren reports Q4 EPS 46c, consensus 42c 11/04/20 Ameren narrows FY20 EPS view to $3.40-$3.55 from $3.40-$3.60, consensus $3.47 11/04/20 Ameren reports Q3 EPS $1.47, consensus $1.47 06/22/21 2021 Energy, Power & Renewables Virtual Conference 05/06/21 Ameren Corp
Initiation	B. Riley starts GT Biopharma with Buy, sees 101% upside in shares » 07:22 04/13/21 04/13 07:22 04/13/21 07:22 GTBP GT Biopharma $10.29 / -0.1 (-0.96%) B. Riley analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events GTBP GT Biopharma $10.29 / -0.1 (-0.96%) 04/12/21 GT Biopharma reports interim results from GTB-3550 TriKE Phase I/II trial 04/08/21 GT Biopharma enrolls tenth patient in TriKE Phase I/II clinical trial 03/17/21 GT Biopharma updates interim results of GTB-3550 clinical trial 03/08/21 GT Biopharma announces preclinical results for ROR1 TriKE product candidate GTBP GT Biopharma $10.29 / -0.1 (-0.96%) 04:47 Today B. Riley GT Biopharma initiated with a Buy at B. Riley 03/17/21 Roth Capital GT Biopharma initiated with a Buy at Roth Capital 11 Feb 00:00 Today GT Biopharma 04/14/21 GT Biopharma 04/15/21 GT Biopharma
Recommendations	Cleveland-Cliffs price target raised to $22 from $21 at B. Riley » 07:20 04/13/21 04/13 07:20 04/13/21 07:20 CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) B. Riley analyst Lucas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 04/12/21 Cleveland-Cliffs announces tentative agreement with USW for 53-month contract 03/31/21 Cleveland-Cliffs rises 13.5% 03/30/21 Cleveland-Cliffs jumps over 6% to $18.33 after EBTIDA guidance 03/30/21 Cleveland-Cliffs sees Q1 adjusted EBITDA about $500M CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 04/09/21 Goldman Sachs Cleveland-Cliffs initiated with a Neutral at Goldman Sachs 03/31/21 B. Riley Securities Cleveland-Cliffs price target raised to $21 from $20 at B. Riley Securities 02/03/21 Credit Suisse U.S. Steel Industry upgraded to Overweight at Credit Suisse 01/26/21 GLJ Research Cleveland-Cliffs downgraded to Hold on 'emerging headwinds' at GLJ Research CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 02/25/21 Cleveland-Cliffs reports Q4 EPS 14c, consensus 22c 01/25/21 Cleveland-Cliffs sees Q4 revenues $2.2B-$2.4B, consensus $1.82B 10/23/20 Cleveland-Cliffs reports Q3 EPS (2c), consensus (10c) 09 Feb CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 03/30/21 Fly Intel: After-Hours Movers 02/09/21 Fly Intel: Pre-market Movers 04/22/21 Cleveland-Cliffs - CLF 04/28/21 Cleveland-Cliffs Inc. 05/11/21 Cleveland-Cliffs CLF Cleveland-Cliffs $17.54 / -0.285 (-1.60%) 03/31/21 Cleveland-Cliffs call volume above normal and directionally bullish 03/29/21 Cleveland-Cliffs call volume above normal and directionally bullish 03/26/21 Cleveland-Cliffs call volume above normal and directionally bullish 03/22/21 Cleveland-Cliffs call volume above normal and directionally bullish
Syndicate	Chewy 6.1M share Block Trade priced at $82.50 » 07:19 04/13/21 04/13 07:19 04/13/21 07:19 CHWY Chewy $84.02 / +0.03 (+0.04%) Morgan Stanley acted as… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CHWY Chewy $84.02 / +0.03 (+0.04%) 03/31/21 Chewy rises 10.3% 03/31/21 Chewy rises 12.4% 03/30/21 Chewy jumps 9% to $87.89 after Q4 earnings beat and above-consensus guidance 02/03/21 GameStop appoints Matt Francis as CTO CHWY Chewy $84.02 / +0.03 (+0.04%) 04/05/21 Evercore ISI Chewy assumed with an Outperform at Evercore ISI 03/31/21 Wolfe Research Chewy initiated with a Peer Perform at Wolfe Research 03/31/21 Wedbush Chewy price target raised to $100 from $90 at Wedbush 03/31/21 Jefferies Chewy price target raised to $105 from $100 at Jefferies CHWY Chewy $84.02 / +0.03 (+0.04%) 03/30/21 Chewy reports Q1 adjusted EPS 5c, consensus (10c) 03/30/21 Chewy sees FY21 revenue $8.85B-$8.95B, consensus $8.85B 03/30/21 Chewy sees Q1 revenue $2.11B-$2.13B, consensus $2.07B 03/30/21 Chewy reports Q4 revenue $2.04B, consensus $1.96B 20 Apr 17 Sep CHWY Chewy $84.02 / +0.03 (+0.04%) 03/08/21 GameStop to pick Ryan Cohen to lead e-commerce shift, Bloomberg reports 02/24/21 GameStop seeks CFO more in line with Cohen's vision, Bloomberg reports 01/16/21 GameStop stock double last week, challenges remain, Barron's says 11/16/20 Chewyco-founder Ryan Cohen wants 'tech-centric' makeover for GameStop, WSJ says CHWY Chewy $84.02 / +0.03 (+0.04%) 04/12/21 Fly Intel: After-Hours Movers 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 GameStop back in spotlight after nominating Cohen as chairman 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 04/14/21 Chewy CHWY Chewy $84.02 / +0.03 (+0.04%) 04/12/21 Unusually active option classes on open April 12th 03/30/21 Chewy options imply 14.5% move in share price post-earnings 03/26/21 Chewy put volume heavy and directionally bearish 03/22/21 Unusually active option classes on open March 22nd
Initiation	B. Riley starts Identiv at Buy, sees 82% upside in shares » 07:18 04/13/21 04/13 07:18 04/13/21 07:18 INVE Identiv $11.75 / +0.25 (+2.17%) B. Riley analyst Craig… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate INVE Identiv $11.75 / +0.25 (+2.17%) 02/11/21 Identiv amended its short term debt facility with EWB 02/09/21 Identiv announces 2021 strategic priorities 02/09/21 Identiv 'well-positioned' to meet 20%-25% revenue growth guidance in 1H21 12/30/20 Identiv announces early repayment of East West Bank term loan INVE Identiv $11.75 / +0.25 (+2.17%) 04/12/21 B. Riley Identiv initiated with a Buy at B. Riley 09/28/20 Northland Identiv benefitting as Apple supports NFC, says Northland 09/22/20 Lake Street Identiv price target raised to $8 after management meeting at Lake Street INVE Identiv $11.75 / +0.25 (+2.17%) 03/04/21 Identiv reports Q4 EPS (5c), consensus (5c) 02/09/21 Identiv sees Q4 revenue $24.6M-$24.8M, consensus $24.94M 11/10/20 Identiv reports Q3 EPS 1c, consensus 0c 10/29/20 Identiv sees Q3 EPS 0c-1c, consensus (2c) 08 Apr

Hot Stocks	Lithia Motors acquires The Suburban Collection in Troy, Michigan » 07:17 04/13/21 04/13 07:17 04/13/21 07:17 LAD Lithia Motors $402.26 / +3.81 (+0.96%) Lithia Motors announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events LAD Lithia Motors $402.26 / +3.81 (+0.96%) 03/30/21 Lithia Motors acquires Avondale Nissan 03/02/21 Lithia Motors acquires five locations in Florida 02/09/21 Lithia Motors acquires two stores in Florida from Fields Auto Group 12/01/20 Lithia Motors acquireds Ramsey Subaru and Mazda in Iowa LAD Lithia Motors $402.26 / +3.81 (+0.96%) 03/11/21 Craig-Hallum Lithia Motors price target raised to $500 from $450 at Craig-Hallum 02/24/21 Citi Lithia Motors price target raised to $385 from $320 at Citi 02/10/21 Fly Intel: Top five analyst downgrades 02/10/21 Morgan Stanley Morgan Stanley cuts Lithia Motors to sell with shares near bull case LAD Lithia Motors $402.26 / +3.81 (+0.96%) 02/03/21 Lithia Motors reports Q4 adjusted EPS $5.46, consensus $5.06 10/21/20 Lithia Motors reports Q3 adj. EPS $6.89, consensus $5.86 01 Oct LAD Lithia Motors $402.26 / +3.81 (+0.96%) 02/10/21 Lithia Motors, Canopy Growth downgrades among today's top calls on Wall Street 12/21/20 Microsoft, Walmart upgrades among today's top calls on Wall Street 04/29/21 Lithia Motors Inc
Hot Stocks	Extreme Networks appoints John Abel as CIO » 07:15 04/13/21 04/13 07:15 04/13/21 07:15 EXTR Extreme Networks $9.47 / +0.06 (+0.64%) Extreme Networks… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 02/17/21 Extreme Networks selected by MLB as official wi-fi solutions provider 10/28/20 Extreme Networks sees Q2 adjusted gross margin 60%-60.6% EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 02/24/21 Lake Street Extreme Networks price target raised to $12 from $8 at Lake Street 02/10/21 B. Riley Securities Extreme Networks price target raised to $12.50 from $11 at B. Riley Securities 01/28/21 Lake Street Extreme Networks price target raised to $8 from $6 at Lake Street 01/28/21 B. Riley Securities Extreme Networks price target raised to $11 from $9.50 at B. Riley Securities EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 02/09/21 Extreme Networks backs Q3 adjusted EPS view 11c-16c, consensus 13c 02/09/21 Extreme Networks reports Q2 adjusted EPS 13c, consensus 14c 01/27/21 Extreme Networks sees Q2 non-GAAP EPS 11c-17c, consensus 11c 01/27/21 Extreme Networks sees Q3 non-GAAP EPS 11c-16c, consensus 8c EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 01/27/21 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference
Hot Stocks	J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use 07:15 04/13/21 04/13 07:15 04/13/21 07:15 JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 07:14 Today FDA, CDC confirm recommendation to pause use of J&J COVID-19 vaccine 04/12/21 Pulmatrix to regain full rights to NSKI portfolio 04/05/21 Cidara, Janssen enter agreement to develop, commercialize AVCs 04/05/21 J&J assumes responsibility of vaccine manufacturing at Emergent facility JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports 04/09/21 J&J in talks for trial in India of COVID-19 vaccine, Business Standard says 04/09/21 EU evaluates J&J vaccine for blood clots, widens AstraZeneca probe, Reuters says 04/08/21 North Carolina halts Johnson&Johnson COVID shots on adverse reactions, AP says JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Fly Intel: Wall Street's top stories at midday 04/20/21 Johnson & Johnson - JNJ 04/22/21 Johnson & Johnson JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish
Hot Stocks	FDA, CDC confirm recommendation to pause use of J&J COVID-19 vaccine » 07:14 04/13/21 04/13 07:14 04/13/21 07:14 JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) In a series of tweets,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/12/21 Pulmatrix to regain full rights to NSKI portfolio 04/05/21 Cidara, Janssen enter agreement to develop, commercialize AVCs 04/05/21 J&J assumes responsibility of vaccine manufacturing at Emergent facility 04/05/21 Emergent BioSolutions receives modified $23M task order from BARDA JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports 04/09/21 J&J in talks for trial in India of COVID-19 vaccine, Business Standard says 04/09/21 EU evaluates J&J vaccine for blood clots, widens AstraZeneca probe, Reuters says 04/08/21 North Carolina halts Johnson&Johnson COVID shots on adverse reactions, AP says JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Fly Intel: Wall Street's top stories at midday 04/20/21 Johnson & Johnson - JNJ 04/22/21 Johnson & Johnson JNJ Johnson & Johnson $161.62 / +0.42 (+0.26%) 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish
Initiation	Lumos Pharma initiated with a Buy at JonesTrading » 07:13 04/13/21 04/13 07:13 04/13/21 07:13 LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) JonesTrading analyst Lina… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) 03/21/21 Lumos Pharma says data shows greater GH response in PGHD from LUM-201 03/04/21 Lumos Pharma announces results of data analyses from PGHD studies 11/10/20 Lumos initiated Phase 2b OraGrowtH210 Trial evaluating oral LUM-201 in PGHD LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) 03/11/21 Stifel Lumos Pharma upgraded to Buy from Hold at Stifel 12/03/20 Fly Intel: Top five analyst initiations 12/03/20 Cantor Fitzgerald Lumos Pharma initiated with an Overweight at Cantor Fitzgerald 12/02/20 Cantor Fitzgerald Lumos Pharma initiated with an Overweight at Cantor Fitzgerald LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) 11/10/20 Lumos Pharma reports Q3 EPS 21c, consensus (64c) 04/27/21 KOL Webinar on LUM-201 04/27/21 Lumos Pharma - LUMO 05/19/21 Lumos Pharma Inc LUMO Lumos Pharma $10.99 / -0.32 (-2.83%) 10/19/20 Six new option listings and ten option delistings on October 19th

Hot Stocks	MEI Pharma completes enrollment in Phase 2 Tidal study » 07:12 04/13/21 04/13 07:12 04/13/21 07:12 MEIP MEI Pharma $3.39 / -0.04 (-1.17%) MEI Pharma and Kyowa… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly MEIP MEI Pharma $3.39 / -0.04 (-1.17%) 04/11/21 MEI Pharma reports preclinical data on Voruciclib ability to regulate MYC 01/04/21 MEI Pharma expands Phase 1b study evaluating zandelisib MEIP MEI Pharma $3.39 / -0.04 (-1.17%) 10/12/20 Brookline MEI Pharma initiated with a Buy at Brookline 09/22/20 Alliance Global Partners MEI Pharma initiated with a Buy at Alliance Global Partners 07/06/20 SunTrust MEI Pharma price target lowered to $12 from $16 at SunTrust 05/29/20 Fly Intel: Top five analyst initiations MEIP MEI Pharma $3.39 / -0.04 (-1.17%) 02/04/21 MEI Pharma reports Q2 EPS (16c), consensus (13c) 11/10/20 MEI Pharma reports Q1 EPS (2c), consensus (8c) MEIP MEI Pharma $3.39 / -0.04 (-1.17%) 12/03/20 Fly Intel: Pre-market Movers
Recommendations	Nvidia price target raised to $700 from $620 at Credit Suisse » 07:12 04/13/21 04/13 07:12 04/13/21 07:12 NVDA Nvidia $608.46 / +33.14 (+5.76%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Nvidia announces eight new Ampere architecture GPUs 04/12/21 Cloudera up 3% to $13.01 after announcing collaboration with Nvidia 04/12/21 Cloudera collaborates with Nvidia to accelerate data analytics, AI in the cloud 04/12/21 Nvidia unveils Nvidia Drive Atlan 'AI center on wheels' NVDA Nvidia $608.46 / +33.14 (+5.76%) 07:08 Today Deutsche Bank Nvidia price target raised to $575 from $560 at Deutsche Bank 06:57 Today Mizuho Nvidia price target raised to $675 from $650 at Mizuho 06:56 Today Susquehanna Nvidia to invest heavily into data center space, says Susquehanna 06:09 Today Barclays Nvidia price target raised to $650 from $600 at Barclays NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Nvidia sees Q1 revenue tracking above $5.3B guide, consensus $5.32B 02/24/21 Nvidia sees Q1 revenue $5.3B +/- 2%, consensus $4.51B 02/24/21 Nvidia reports Q4 EPS $3.10, consensus $2.81 02/24/21 Notable companies reporting after market close NVDA Nvidia $608.46 / +33.14 (+5.76%) 03/23/21 Nintendo to use upgraded Nvidia chip in 2021 Switch model, Bloombreg reports 03/09/21 Some Xbox users can now stream Steam games through web browser, VGC says 02/12/21 Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says 02/12/21 FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/09/21 The Intersection: Crypto and Wall Street This Week 03/26/21 The Intersection: Crypto and Wall Street This Week 03/23/21 Game On: Microsoft in talks to buy Discord as Sony acquires EVO NVDA Nvidia $608.46 / +33.14 (+5.76%) 02/25/21 NVIDIA call buyer realizes 13% same-day gains 01/11/21 Early notable gainers among liquid option names on January 11th 11/18/20 NVIDIA options imply 8.0% move in share price post-earnings 11/04/20 NVIDIA call buyer realizes 8% same-day gains
Upgrade	Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility » 07:11 04/13/21 04/13 07:11 04/13/21 07:11 BMY Bristol-Myers $62.70 / +0.09 (+0.14%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 04/11/21 Bristol-Myers announces results from CheckMate -816 study 04/08/21 Bristol-Myers reports 'positive' results from Phase 3 CheckMate -648 trial 04/01/21 Agios Pharmaceuticals enters agreement to repurchase stock from Bristol-Myers 03/30/21 Huyabio International enters clinical collaboration agreement with Bristol-Myers BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 06:08 Today Truist Bristol-Myers upgraded to Buy from Hold at Truist 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/08/21 BofA Gartner added to US 1 List, Bristol-Myers removed at BofA 02/12/21 Morgan Stanley Amgen court decision may have readthrough for Gilead, says Morgan Stanley BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 11/21/20 Week in review: How Trump's policies moved stocks 04/29/21 Bristol-Myers - BMY 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 01/28/22 PDUFA Date for Mavacamten 05/04/21 Bristol Myers Squibb Co BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish
Recommendations	TripAdvisor price target raised to $29 from $24 at Jefferies » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 TRIP TripAdvisor $51.17 / -1.27 (-2.42%) Jefferies analyst Brent… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 03/24/21 TripAdvisor, Reckitt announce partnership 03/22/21 TripAdvisor announces $300M convertible notes offering 02/18/21 TripAdvisor sees Q1 revenue, adjusted EBITDA roughly in line with 4Q20 02/18/21 TripAdvisor: January revenue performance dipped slightly relative to December TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 04/05/21 Evercore ISI TripAdvisor assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research TripAdvisor initiated with a Peer Perform at Wolfe Research 03/12/21 Truist TripAdvisor price target raised to $62 from $48 at Truist 03/02/21 Citi TripAdvisor upgraded to Buy from Neutral at Citi TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 02/18/21 TripAdvisor reports Q4 adjusted EPS (41c), consensus (25c) 02/18/21 Notable companies reporting after market close 11/06/20 TripAdvisor expects Q4 revenue to be modestly lower than Q3, consensus $174.93M 11/05/20 TripAdvisor reports Q3 adjusted EPS (17c), consensus (26c) TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 01/08/21 Another Tesla upgrade among today's top calls on Wall Street 12/02/20 Fly Intel: Pre-market Movers TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 03/24/21 Unusually active option classes on open March 24th 03/05/21 Unusually active option classes on open March 5th 03/03/21 TripAdvisor call volume above normal and directionally bullish 02/26/21 TripAdvisor call volume above normal and directionally bullish
Hot Stocks	Bausch Health eye health business announces GOBI trial meets all endpoints » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 BHC Bausch Health $29.93 / -0.86 (-2.79%) Bausch + Lomb, a global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BHC Bausch Health $29.93 / -0.86 (-2.79%) 04/07/21 Bausch Health's ClearVisc viscosurgical device approved by FDA 03/31/21 Bausch Health to sell Amoun Pharmaceuticals to ADQ for about $740M 03/11/21 Bausch Health appoints Sam Eldessouky as CFO effective June 1 02/26/21 Bausch Health to reduce debt by $100M BHC Bausch Health $29.93 / -0.86 (-2.79%) 03/24/21 Fly Intel: Top five analyst downgrades 03/24/21 BofA BofA downgrades Bausch Health to Underperform, sees stock 'priced to perfection' 03/24/21 BofA Bausch Health downgraded to Underperform from Neutral at BofA 03/16/21 H.C. Wainwright Bausch Health price target raised to $55 from $50 at H.C. Wainwright BHC Bausch Health $29.93 / -0.86 (-2.79%) 02/24/21 Bausch Health sees FY21 revenue $8.6B-$8.8B, consensus $8.5B 02/24/21 Bausch Health reports Q4 revenue $2.21B, consensus $2.17B 01/12/21 Bausch Health sees Q4 revenue over $2.20B, consensus $2.12B 11/03/20 Bausch Health reports Q3 adjusted EBITDA $948M, consensus $844.9M BHC Bausch Health $29.93 / -0.86 (-2.79%) 12/29/20 Fly Intel: Pre-market Movers 11/03/20 Fly Intel: Pre-market Movers 05/04/21 Bausch Health - BHC BHC Bausch Health $29.93 / -0.86 (-2.79%) 03/09/21 Bausch Health call volume above normal and directionally bullish 03/03/21 Bausch Health put volume heavy and directionally bearish 01/05/21 Bausch Health call volume above normal and directionally bullish 01/04/21 Bausch Health call volume above normal and directionally bullish

Recommendations	Expedia price target raised to $175 from $145 at Jefferies » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 EXPE Expedia $171.77 / -3.14 (-1.80%) Jefferies analyst Brent… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options EXPE Expedia $171.77 / -3.14 (-1.80%) 02/11/21 Expedia sees Q1 adjusted EBITDA down significantly. 02/11/21 Expedia reports Q4 room night growth down 61% 12/08/20 Porch.com appoints Matthew Cullen as general counsel, secretary 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter EXPE Expedia $171.77 / -3.14 (-1.80%) 04/05/21 Evercore ISI Expedia assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research Expedia initiated with a Peer Perform at Wolfe Research 03/30/21 Gordon Haskett Expedia initiated with a Buy at Gordon Haskett 03/25/21 Morgan Stanley Expedia price target raised to $200 from $160 at Morgan Stanley EXPE Expedia $171.77 / -3.14 (-1.80%) 02/11/21 Expedia reports Q4 adjusted EPS ($2.64), consensus ($1.97) 02/11/21 Notable companies reporting after market close 11/04/20 Expedia reports Q3 adjusted EPS (22c), consensus (79c) 11/04/20 Notable companies reporting after market close EXPE Expedia $171.77 / -3.14 (-1.80%) 04/08/21 Expedia adds tool to check Covid restrictions amid travel lust, The Verge says 11/20/20 Tech giants threaten to exit Pakistan over censorship law, TechCrunch says 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports EXPE Expedia $171.77 / -3.14 (-1.80%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/30/21 Alphabet, Roku upgrades among today's top calls on Wall Street 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday EXPE Expedia $171.77 / -3.14 (-1.80%) 04/07/21 Expedia call volume above normal and directionally bullish 02/03/21 Unusually active option classes on open February 3rd 01/25/21 Expedia call volume above normal and directionally bullish 12/16/20 Expedia call volume above normal and directionally bullish
Recommendations	Nasdaq price target raised to $164 from $160 at Deutsche Bank » 07:09 04/13/21 04/13 07:09 04/13/21 07:09 NDAQ Nasdaq $156.17 / +0.15 (+0.10%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 03/16/21 PureStream Trading Technologies selects Nasdaq to power its ATS 02/08/21 Nasdaq gets Investment Canada Act approval for Verafin, acquisition 02/02/21 Tradeweb Markets to acquire Nasdaq fixed income trade platform for $190M 02/02/21 Nasdaq to sell U.S. fixed income business to Tradeweb Markets NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 04/09/21 UBS Nasdaq price target raised to $178 from $170 at UBS 04/08/21 Piper Sandler Nasdaq price target raised to $165 from $160 at Piper Sandler 01/29/21 Citi Nasdaq price target raised to $147 from $144 at Citi 01/28/21 Barclays Nasdaq price target raised to $160 from $155 at Barclays NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 01/27/21 Nasdaq reports Q4 adjusted EPS $1.60, consensus $1.45 10/21/20 Nasdaq reports Q3 adj. EPS $1.58, consensus $1.45 NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 03/05/21 Robinhood picks Nasdaq for eventual IPO, CNBC reports 02/12/21 Senate Republicans urge SEC to reject Nasdaq diversity rules, Reuters reports NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 03/05/21 Fly Intel: Wall Street's top stories for Friday 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Morgan Stanley sees needed AML fix potentially slowing Square's Cash App growth 11/19/20 Fly Intel: Wall Street's top stories at midday 04/21/21 Nasdaq - NDAQ NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 12/07/20 Early notable gainers among liquid option names on December 7th
Upgrade	Booking Holdings upgraded to Buy on coming travel rebound at Jefferies » 07:09 04/13/21 04/13 07:09 04/13/21 07:09 BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 03/25/21 JetBlue announces launch of Paisly by JetBlue, a new travel website 02/24/21 Booking Holdings CEO says 'more confident than ever' in eventual travel recovery 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 11/16/20 Lone Pine buys Square, exits Visa in Q3 BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 06:48 Today Jefferies Booking Holdings upgraded to Buy from Hold at Jefferies 04/05/21 Evercore ISI Booking Holdings assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research Booking Holdings initiated with an Outperform at Wolfe Research 03/30/21 Gordon Haskett Booking Holdings initiated with a Hold at Gordon Haskett BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 02/24/21 Booking Holdings reports Q4 adjusted EPS (57c), consensus ($4.28) 02/24/21 Notable companies reporting after market close 11/05/20 Booking CEO says COVID-19 surge to impact travel in near-term 11/05/20 Booking Holdings reports Q3 adjusted EPS $12.27, consensus $14.13 BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/30/21 Alphabet, Roku upgrades among today's top calls on Wall Street 03/22/21 Snap downgrade, PepsiCo upgrade among today's top calls on Wall Street 01/04/21 Airbnb under pressure as Wall Street analysts roll out coverage following IPO 05/24/21 Global Technology, Media & Communications Virtual Conference BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 01/04/21 Booking Holdings put volume heavy and directionally bearish
Downgrade	Idacorp downgraded to Neutral from Buy at BofA » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 IDA Idacorp $100.06 / +0.49 (+0.49%) BofA analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events IDA Idacorp $100.06 / +0.49 (+0.49%) 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 01/06/21 Wells Fargo Idacorp downgraded to Underweight from Equal Weight at Wells Fargo 05/04/20 Sidoti Idacorp upgraded to Buy on valuation at Sidoti 05/04/20 Sidoti Idacorp upgraded to Buy from Neutral at Sidoti IDA Idacorp $100.06 / +0.49 (+0.49%) 02/18/21 Idacorp sees FY21 EPS $.60-$4.80, consensus $4.75 02/18/21 Idacorp reports Q4 EPS 74c, consensus 67c 04/29/21 Idacorp - IDA 05/20/21 IDACORP, Inc.
Hot Stocks	Evogene's Biomica demonstrates efficacy of BMC128 in studies » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 EVGN Evogene $4.37 / -0.26 (-5.62%) Biomica, a subsidiary of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options EVGN Evogene $4.37 / -0.26 (-5.62%) 03/25/21 Evogene subsidiary, Tikun Olam-Cannbit enter pact for cannabis distribution 03/17/21 Evogene's Ag-Seed division, Plastomics enter collaborative agreement 02/24/21 Evogene subsidiary, Cannbit enter collaboration for medical cannabis products 12/29/20 Lavie Bio targets product launch for LAV311, LAV312 in 2024 EVGN Evogene $4.37 / -0.26 (-5.62%) 11/30/20 Cantor Fitzgerald Cantor Fitzgerald starts 'highly underappreciated' Evogene at Overweight 11/30/20 Cantor Fitzgerald Evogene initiated with an Overweight at Cantor Fitzgerald 04/21/21 Evogene Ltd. EVGN Evogene $4.37 / -0.26 (-5.62%) 02/03/21 new option listings on February 3rd

Events

Earnings calls, analyst events, roadshows and more

IMCR
Today at 07:30

Immunocore - IMCR Conference Calls
BFRA
Today at 08:00

Biofrontera - BFRA Conference Calls
OGI
Today at 08:00

Organigram - OGI Conference Calls
EARS
Today at 08:00

Auris Medical - EARS Conference Calls
Today at 08:30

Consumer Price Index M/M: March 2021 Government Event
Today at 08:30

Consumer Price Index Y/Y: March 2021 Government Event
Today at 08:30

CPI Ex-Food & Energy M/M: March 2021 Government Event
Today at 08:30

CPI Ex Food & Energy Y/Y: March 2021 Government Event
KKR
Today at 08:30

KKR & Co. Inc. Firm Sponsored Meetings
MGA
Today at 08:30

Magna International, Inc. CL A Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank $35.10 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares
Fri	No deals

View All Syndicate Announcements »

Barclays boosts Cornerstone target, says start paying attention again

TODAY'S FREE FLY STORIES

Get Full Fly Access